MODERNA

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke MODERNA wurde als Wortmarke am 13.05.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 25. Mai 2023

Markenform Wortmarke
Aktenzeichen 1542001
Länder Kanada Schweiz Algerien Europäische Gemeinschaft Israel Iran Island Japan Kasachstan Liechtenstein Monaco Montenegro Malaysia Pakistan Singapur Thailand Ukraine
Basismarke US Nr. 88903508, 06. Mai 2020
Anmeldedatum 13. Mai 2020
Ablaufdatum 13. Mai 2030

Markeninhaber

200 Technology Square, 2nd Floor
Cambridge MA 02139
US

Markenvertreter

P.O. Box 1022 Minneapolis MN 55440-1022 US

Waren und Dienstleistungen

01 Biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for in vivo, ex vivo, on vivo or in vitro scientific research and medical research, and for use in the manufacture of food or nutritional supplement; biochemicals, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids for use in the manufacture of pharmaceuticals for treating cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; reagents for testing sterility of pharmaceuticals; diagnostic reagents for scientific or research use; chemicals for use in biotherapeutics, biosimilars and therapeutics product development and manufacturing processes; polypeptide encoding nucleic acids for laboratory use
05 Medical, biological and pharmaceutical preparations for scientific, research, medical, or pharmaceutical use, namely, preparations for treating cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders; medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; medical diagnostic reagents; pharmaceuticals, namely, vaccines, medicines, biologics, biotherapeutics, biosimilars and therapeutics
42 Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
10. Mai 2023 2023/19 Gaz IS Ablehnung
10. Mai 2023 2023/19 Gaz MY Ablehnung
19. April 2023 2023/16 Gaz TH Ablehnung
29. März 2023 2023/16 Gaz CH RAW: Rule 18ter(2)(ii) GP following a provisional refusal
03. November 2022 2022/44 Gaz LI Ablehnung
29. Oktober 2022 2022/44 Gaz ME Ablehnung
16. August 2022 2022/33 Gaz KZ Ablehnung
25. Juli 2022 2022/30 Gaz UA Ablehnung
21. Mai 2022 2022/27 Gaz SG RAW: Rule 18ter(2)(ii) GP following a provisional refusal
11. Mai 2022 2022/19 Gaz DZ Ablehnung
12. Januar 2022 2022/2 Gaz MC Ablehnung
11. Januar 2022 2022/3 Gaz IR Ablehnung
08. November 2021 2021/46 Gaz CA Ablehnung
04. Oktober 2021 2021/43 Gaz IL RAW: Rule 18ter(2)(i) GP following a provisional refusal
03. September 2021 JP Ablehnung
02. September 2021 2021/43 Gaz US Korrektur
26. August 2021 2021/35 Gaz JP Ablehnung
24. März 2021 2021/13 Gaz CH Ablehnung
10. Dezember 2020 2020/53 Gaz IL Ablehnung
10. Dezember 2020 2020/51 Gaz EM Ablehnung
11. November 2020 2020/47 Gaz SG Ablehnung
29. Juli 2020 2020/33 Gaz US Korrektur
13. Mai 2020 2020/28 Gaz US Eintragung

ID: 141542001